Most cancer deaths occur in organs without routine screening tests available. GRAIL's Galleri blood test aims to find these ...

Early-stage cancer detection startup Grail, which has investors including Amazon CEO Jeff Bezos, has filed to go public, according to a Sept. 9 CNBC report. 1. DNA-sequencing machine developer ...

By: Gretchen Stipec, M.D., radiologist, Cancer Institute, Long Beach Medical Center Seniors account for nearly 28% of all new ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...

CHICAGO -- Hundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday. Grail said a software glitch related to their telemedicine ...

We recently published 10 Market Stars Behind Millionaire-Making in 2025. Grail Inc. (NASDAQ:GRAL) is one of the top performers. Grail Inc. soared by 379.5 percent in 2025, with the rally primarily ...

MENLO PARK, Calif., Oct. 17, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...

Grail (NASDAQ:GRAL) announced Wednesday that its Galleri test led to improved cancer detection when added to standard-of-care cancer screening in its PATHFINDER 2 registrational trial. Citing topline ...

SAN FRANSISCO, CA, UNITED STATES, November 7, 2025 /EINPresswire.com/ -- GenieMD today announced it will integrate GRAIL’s groundbreaking Galleri ® multi-cancer ...

Galleri Accurately Predicted the Location of the Cancer in Almost All Cases Initially Considered as False Positives, Reinforcing the Value of Galleri's CSO Capability MENLO PARK, Calif. and OXFORD, ...

Grail Inc. (NASDAQ:GRAL) is one of the best emerging technology stocks to invest in. On December 1, Morgan Stanley assumed coverage of Grail with an Equal Weight rating and a price target of $110, ...